CELERIS THERAPEUTICS
Celeris Therapeutics is an AI-first drug discovery company that develops proximity-inducing compounds (PICs), focusing on PIC degraders for diseases with high unmet medical needs, such as Parkinson's and various types of cancers. Celeris Therapeutics has developed the Celeris One platform to streamline the development of degraders and, most importantly, rationalize their design. Celeris One leverages structure-based geometric deep learning to prioritize specific E3 ligases, design linkers, and ... select the most active compounds for synthesis. An in-house automated lab quickly generates experimental data for additional optimization cycles. Celeris Therapeutics collaborates with pharma and biotech companies to jointly discover and develop small-molecule degrader medicines for all therapeutic areas. It is also developing an in-house drug pipeline. Celeris Therapeutics has offices in Menlo Park, CA, and Graz, Austria.
CELERIS THERAPEUTICS
Industry:
Artificial Intelligence Biotechnology Information Technology Life Science Pharmaceutical
Founded:
2021-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.celeristx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
BenchSci
BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery.
Exogene
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.
Genesis Therapeutics
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Numerate
Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.
Protai
Protai is an AI-powered drug discovery startup.
Q-State Biosciences
Q-State has developed world-leading technologies and proprietary approaches for probing rare and genetic CNS conditions.
Spring Discovery
Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Troy Medicare
Troy Medicare is arming independent pharmacies with a health plan and platform tailored to their most vulnerable patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
i&i Prague
i&i Prague investment in Seed Round - Celeris Therapeutics
R42 Group
R42 Group investment in Seed Round - Celeris Therapeutics
APX Ventures
APX Ventures investment in Seed Round - Celeris Therapeutics
Pace Ventures Enigma
Pace Ventures Enigma investment in Seed Round - Celeris Therapeutics
Longevitytech.fund
Longevitytech.fund investment in Seed Round - Celeris Therapeutics
APX Ventures
APX Ventures investment in Pre Seed Round - Celeris Therapeutics
R42 Group
R42 Group investment in Pre Seed Round - Celeris Therapeutics
Longevitytech.fund
Longevitytech.fund investment in Pre Seed Round - Celeris Therapeutics
Official Site Inspections
http://www.celeristx.com
- Host name: dedivirt714.your-server.de
- IP address: 195.201.6.13
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
